Latest / Clinical Guideline InSights
MASCC Febrile Neutropenia in Patients Treated with Chemotherapy/Immune Checkpoint Inhibition
The 2026 Febrile Neutropenia in Patients Treated with Chemotherapy/Immune Checkpoint Inhibition consensus statement, highlighting key position points across MASCC scoring, treatment, and more.
Febrile Neutropenia in Patients Treated with Chemotherapy/Immune Checkpoint Inhibition
Multinational Association of Supportive Care in Cancer
July 29, 2026
Guideline Summary: https://www.guidelinecentral.com/guideline/5239329/
Full-Text: https://link.springer.com/article/10.1007/s00520-026-11045-7
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.